Bortezomib Just for Induction or Also for Maintenance in Myeloma Patients With Renal Impairment?

Haematologica - Italy
doi 10.3324/haematol.2013.100982
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Ferrata Storti Foundation (Haematologica)

Related search

Bortezomib-Based Consolidation or Maintenance Therapy for Multiple Myeloma: A Meta-Analysis

Blood Cancer Journal
OncologyHematology
2020English

Primary Therapy With Single Agent Bortezomib as Induction, Maintenance and Re-Induction in Patients With High-Risk Myeloma: Results of the ECOG E2A02 Trial

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2010English

Bortezomib for the Treatment of Multiple Myeloma Patients

Health Technology Assessment
MedicineHealth Policy
2009English

Optimization of Dalbavancin in Patients With Hepatic or Renal Impairment

Pharmacology & Pharmacy
2020English

Efficacy and Safety of Reduced-Intensity Induction Therapy With a Bortezomib-Based Regimen in Elderly Patients With Multiple Myeloma

Therapeutic Advances in Hematology
Hematology
2012English

Peripheral Neuropathy Induced by Subcutaneous Bortezomib-Based Induction Therapy for Newly Diagnosed Multiple Myeloma

Haematologica
Hematology
2014English

Bortezomib Overcomes the Negative Prognostic Impact of Renal Impairment in a Newly Diagnosed Elderly Patient With Multiple Myeloma: A Case Report

Oncology Letters
Cancer ResearchOncology
2017English

Final Overall Survival Results of a Randomized Trial Comparing Bortezomib Plus Pegylated Liposomal Doxorubicin With Bortezomib Alone in Patients With Relapsed or Refractory Multiple Myeloma

Cancer
Cancer ResearchOncology
2016English

Efficacy of Subcutaneous Bortezomib in the Management of Patients With Multiple Myeloma or Relapsed Mantle Cell Lymphoma

Clinical Medicine Insights: Therapeutics
MedicinePharmacologyPharmaceutical Science
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy